Clinical Trials Directory

Trials / Sponsors / HUYABIO International, LLC.

HUYABIO International, LLC.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer
Phase 12022-08-01
TerminatedA Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
Phase 22022-02-15
Active Not RecruitingA Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer
Phase 12021-12-13
Active Not RecruitingStudy Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Me
Unresectable or Metastatic Melanoma, Progressive Brain Metastasis
Phase 32021-08-12
Active Not RecruitingA Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)
Atrial Fibrillation
Phase 22021-06-01
CompletedDrug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
Drug-drug Interaction
Phase 12021-02-21
CompletedA Phase 1 Study of HBI-3000
Atrial Fibrillation
Phase 12017-10-17
CompletedEfficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Peripheral T-Cell Lymphoma (PTCL)
Phase 22016-11-01
CompletedEfficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)
Adult T-Cell Lymphoma (ATL)
Phase 22016-11-01
CompletedStudy of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Melanoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer
Phase 1 / Phase 22016-08-01
WithdrawnDose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Met
Breast Cancer
Phase 12015-12-01
CompletedSafety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Phase 12014-03-01